JPRN-UMIN000031675招募中未知
Biomarker study of "A Phase III Trial of Docetaxel plus S-1 versus S-1 Alone in the Treatment of Curatively Resected Stage III Gastric Cancer (JACCRO GC-07(START-2))" - Biomarker study of "A Phase III Trial of Docetaxel plus S-1 versus S-1 Alone in the Treatment of Curatively Resected Stage III Gastric Cancer (JACCRO GC-07(START-2))"
Japan Clinical Cancer Research Organization (JACCRO)0 个研究点目标入组 800 人开始时间: 2018年3月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients who are considered as inadequate for study enrollment by investigators. (2) Patients who refuse the use of samples for study.
研究者
相似试验
进行中（未招募）
3 期
A Phase III clinical study of LF111 in Japanese women desiring contraceptioJPRN-jRCT2031210556Kikuyama Ryoko260
进行中（未招募）
3 期
A phase III clinical study in patients with active rheumatoid arthritis who show an inadequate response or intolerance to previous or current treatmentRheumatoid ArthritisJPRN-jRCT2011220026Okugaito Izumi113
招募中
1 期
[68Ga]Ga-PentixaFor-PET imaging for staging of marginal zone lymphomaMarginal Zone LymphomaMedDRA version: 20.0Level: PTClassification code: 10076596Term: Marginal zone lymphoma Class: 100000004864CTIS2022-500918-25-00Pentixapharm GmbH148
进行中（未招募）
1 期
Clinical study phase III evaluating the efficacy of Diffusil H Forte sprayEUCTR2007-002478-76-CZybar a.s.110
招募中
3 期
A Phase 3 clinical study to determine the pharmacokinetics, safety and efficacy of rVWF:rFVIII and rVWF in the treatment of bleeding episodes in subjects diagnosed with von Willebrand diseaseCoagulation disorderHereditary deficiency of Von Willebrand Factor in blood1006447710005330NL-OMON38008Baxter4